Stay updated with breaking news from Bruce Rowlands. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CONSOLIDATED FINANCIAL STATEMENTS AS AT AND FOR THE YEARS ENDED DECEMBER 31, 2023, 2022 and 2021 REPORT OF INDEPENDENT REGISTERED PUBLIC...
XORTX Therapeutics Inc.: XORTX Files New Provisional Patent to Treat and Protect Individuals Most at Risk to Severe Viral Infection CALGARY, AB / ACCESSWIRE / March 8, 2021 / XORTX Therapeutics Inc. XORTX" or the " Company") (CSE:XRX) (OTCQB:XRTXF), a biopharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, with late-stage clinical programs, is pleased to announce the filing of a new provisional patent application entitled "Compositions and Methods for Enhancing Anti-Viral Therapies". This provisional patent was filed with the US Patent Office ...
XORTX Therapeutics Inc.: XORTX to Present at BIO CEO and Investor Conference; Strategies to Decrease Acute and Chronic Kidney Injury, Co-morbidity and Mortality XORTX Therapeutics Inc. XORTX" or the " Company") (CSE:XRX)(OTCQB:XRTXF), a biopharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, announces that the Company is participating in the BIO CEO and Investor Digital Conference to be held virtually February 16-18, 2021. Dr. Allen Davidoff, XORTX's President and CEO will provide an overview of the Company's upcoming, first-in-class kidney di...